NCT04611880 · Interventional trial
Crizanlizumab for Treatment of Retinal Vasculopathy With Cerebral Leukoencephalopathy (RVCL)
Overall registry status Completed
Phase 2
Conditions RVCL - Retinal Vasculopathy Cerebral Leukoencephalopathy
Delaware Valley sites
- Perelman School of Medicine; University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory